Overview
Flourish is an artificial intelligence company that develops energy-efficient artificial intelligence systems using neuroscience and connectomics research [1]. The company operates within the New York artificial intelligence sector [1].
Business address: 111 Buckingham Palace Road, London, England, SW1W . [4]
Funding & milestones
1 events found for Flourish · 2026
VentureVenture / equityDetails$500M
Reported amount $500,000,000
Source not attached to this recordDeal record
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Leadership & org chart
Alumni 1 went on to found or lead
Simon GelinasHead of Data Science→Founder at SiGe.Ai
Backers
Lux Capital
New York and Silicon Valley venture firm investing in counter-conventional science and technology companies
Lux Capital
A venture capital firm that invests in emerging science and technology companies.
- PJeff Bezos
Founder and executive chairman of Amazon, founder of Blue Origin and owner of The Washington Post, and an active angel investor in technology startups.
Catalio Capital Management
Catalio Capital Management is a New York-based investment firm with $2B in assets under management that invests in innovative healthcare companies across private equity, venture, public equities, and credit markets at all stages and throughout the capital structure.
GV
GV supports innovative founders across multiple stages and sectors, from artificial intelligence and life sciences to consumer platforms, enterprise software, and frontier technology. Launched as Google Ventures in 2009, GV oversees more than $10 billion in assets under management. Our operating partners support founding teams at every stage of company-building across executive talent, design, communications, and marketing. GV is a non-strategic venture capital firm that invests independently f
Catalio Capital Management
An investment firm that provides capital and expertise to healthcare and biomedical companies across private equity, public equities, and credit markets.
Something wrong or missing? Send an update. Fixed within 24 hours.